2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Von Koch Thomas | 10% Owner | 8,383,577 | Jul 25, 2025 |
| TomEnterprise AB | 10% Owner | 8,383,577 | Jul 25, 2025 |
| TomEnterprise Private AB | 10% Owner | 8,383,577 | Jul 25, 2025 |
| Stahlberg Jan | 10% Owner | 7,764,465 | Sep 4, 2025 |
| Trill Ab | 10% Owner | 7,764,465 | Sep 4, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Jan 6, 2026 | Parsons James T. | Director | Neutral | 90.0 | +10,095 | 11.49% | ✗ | - |
| Jan 2, 2026 | Jan 6, 2026 | Giuffre Randall Michael | Director | Neutral | 77.5 | +6,175 | 1.41% | ✗ | - |
| Jan 2, 2026 | Jan 6, 2026 | Semba Charles Pauling | Director | Neutral | 85.0 | +3,355 | 7.52% | ✗ | - |
| Nov 17, 2025 | Dec 8, 2025 | STAHLBERG JAN | 10% Owner | Buy | 100.0 | +1,061,277 | 13.67% | ✗ | $7.6M |
| Nov 21, 2025 | Nov 25, 2025 | Parsons James T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 11, 2025 | Nov 3, 2025 | Krop Julie | Chief Marketing Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 3, 2025 | Krop Julie | Chief Marketing Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 13, 2025 | Sep 4, 2025 | STAHLBERG JAN | 10% Owner | Buy | 100.0 | +1,000,000 | 14.78% | ✗ | $6M |
| Jul 23, 2025 | Jul 25, 2025 | STAHLBERG JAN | 10% Owner | Buy | 100.0 | +1,542,857 | 29.55% | ✗ | $5.4M |
| Jul 23, 2025 | Jul 25, 2025 | Von Koch Thomas | 10% Owner | Buy | 100.0 | +2,857,142 | 51.70% | ✗ | $10M |
| Jul 23, 2025 | Jul 25, 2025 | JACINTO RICHARD II | 10% Owner | Buy | 95.0 | +400,000 | 8.77% | ✗ | $1.4M |
| Jun 1, 2025 | Jun 3, 2025 | Wambeke David J. | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2025 | Jun 3, 2025 | Semba Charles Pauling | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2025 | Jun 3, 2025 | Pauls Dietrich John | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2025 | Jun 3, 2025 | Parsons James T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2025 | Jun 3, 2025 | Lewis Tanya | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2025 | Jun 3, 2025 | Kuntz Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2025 | Jun 3, 2025 | Kellen Scott | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2025 | Jun 3, 2025 | Giuffre Randall Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 7, 2025 | Apr 8, 2025 | Pilnik Richard D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 20, 2025 | Feb 24, 2025 | O'Connor Daniel J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 24, 2025 | O'Connor Daniel J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 13, 2025 | Feb 18, 2025 | Giuffre Randall Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Parsons James T. | Director | Neutral | 90.0 | +15,917 | 26.56% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Giuffre Randall Michael | Director | Neutral | 82.5 | +10,861 | 2.64% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Kuntz Richard | Director | Neutral | 90.0 | +9,925 | 69.48% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Pilnik Richard D. | Director | Neutral | 82.5 | +10,393 | 3.73% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Semba Charles Pauling | Director | Neutral | 90.0 | +5,290 | 13.45% | ✗ | - |
| Jun 28, 2024 | Jul 1, 2024 | Von Koch Thomas | 10% Owner | Buy | 100.0 | +1,200,000 | 27.74% | ✗ | $3M |
| Jun 28, 2024 | Jul 1, 2024 | STAHLBERG JAN | 10% Owner | Buy | 100.0 | +1,200,000 | 29.84% | ✗ | $3M |
| Jun 1, 2024 | Jun 3, 2024 | Wambeke David J. | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2024 | Jun 3, 2024 | Kellen Scott | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2024 | Jun 3, 2024 | Cundari Dominic R | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2024 | Jun 3, 2024 | Pauls Dietrich John | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2024 | Jun 3, 2024 | Semba Charles Pauling | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2024 | Jun 3, 2024 | Pilnik Richard D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2024 | Jun 3, 2024 | Parsons James T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2024 | Jun 3, 2024 | Lewis Tanya | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2024 | Jun 3, 2024 | Kuntz Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2024 | Jun 3, 2024 | Giuffre Randall Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 22, 2024 | Jan 23, 2024 | Lorianne Masuoka K. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2024 | Lorianne Masuoka K. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2024 | Jan 2, 2024 | Semba Charles Pauling | Director | Neutral | 90.0 | +9,375 | 31.31% | ✗ | - |
| Jan 2, 2024 | Jan 2, 2024 | Kuntz Richard | Director | Neutral | 90.0 | +14,285 | 100.00% | ✗ | - |
| Jan 2, 2024 | Jan 2, 2024 | Pilnik Richard D. | Director | Neutral | 90.0 | +30,357 | 12.23% | ✗ | - |
| Jan 2, 2024 | Jan 2, 2024 | Parsons James T. | Director | Neutral | 90.0 | +21,428 | 55.64% | ✗ | - |
| Jan 2, 2024 | Jan 2, 2024 | Giuffre Randall Michael | Director | Neutral | 82.5 | +19,196 | 4.90% | ✗ | - |
| Nov 16, 2023 | Nov 16, 2023 | Wambeke David J. | Chief Business Officer | Buy | 83.8 | +20,000 | 3.94% | ✗ | $49.2K |
| Jun 23, 2023 | Jun 27, 2023 | Von Koch Thomas | 10% Owner | Buy | 100.0 | +1,470,588 | 51.49% | ✗ | $5M |
| Jun 27, 2023 | STAHLBERG JAN | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 23, 2023 | Jun 26, 2023 | Giuffre Randall Michael | Director | Buy | 97.5 | +50,000 | 14.62% | ✗ | $254.2K |
| Jun 23, 2023 | Jun 26, 2023 | Pauls Dietrich John | CEO | Buy | 91.3 | +12,787 | 22.91% | ✗ | $50K |
| Jun 23, 2023 | Jun 26, 2023 | Semba Charles Pauling | Director | Buy | 91.3 | +12,787 | 74.53% | ✗ | $50K |
| Jun 23, 2023 | Jun 26, 2023 | Kellen Scott | CFO | Buy | 91.3 | +10,000 | 44.86% | ✗ | $39.1K |
| Jun 23, 2023 | Jun 26, 2023 | Wambeke David J. | Chief Business Officer | Buy | 90.0 | +38,364 | 8.18% | ✗ | $150K |
| Jun 23, 2023 | Jun 26, 2023 | Pilnik Richard D. | Director | Buy | 95.0 | +38,363 | 18.28% | ✗ | $150K |
| Jun 23, 2023 | JACINTO RICHARD II | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 1, 2023 | Jun 2, 2023 | Daves Julie VanOrsdel | SVP Clinical Development Oper. | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2023 | Jun 2, 2023 | Cundari Dominic R | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2023 | Jun 2, 2023 | Gruis Kirsten L | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2023 | Jun 2, 2023 | Kellen Scott | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2023 | Jun 2, 2023 | Pauls Dietrich John | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2023 | Jun 2, 2023 | Semba Charles Pauling | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2023 | Jun 2, 2023 | Pilnik Richard D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2023 | Jun 2, 2023 | Parsons James T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2023 | Jun 2, 2023 | Lewis Tanya | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2023 | Jun 2, 2023 | Giuffre Randall Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 30, 2023 | May 30, 2023 | Kuntz Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 30, 2023 | Kuntz Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 10, 2023 | Apr 11, 2023 | Wambeke David J. | Chief Business Officer | Buy | 97.5 | +468,750 | 100.00% | ✗ | $750K |
| Apr 11, 2023 | Wambeke David J. | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 1, 2023 | Mar 6, 2023 | Lewis Tanya | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 6, 2023 | Lewis Tanya | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 3, 2023 | Jan 3, 2023 | Giuffre Randall Michael | Director | Neutral | 90.0 | +35,130 | 11.45% | ✗ | - |
| Jan 3, 2023 | Jan 3, 2023 | Burroughs Amy L. | Director | Neutral | 90.0 | +17,156 | 30.56% | ✗ | - |
| Jan 3, 2023 | Jan 3, 2023 | Semba Charles Pauling | Director | Neutral | 90.0 | +17,156 | 100.00% | ✗ | - |
| Jan 3, 2023 | Jan 3, 2023 | Pilnik Richard D. | Director | Neutral | 90.0 | +55,555 | 36.00% | ✗ | - |
| Dec 8, 2022 | Dec 12, 2022 | Giuffre Randall Michael | Director | Buy | 95.0 | +57,079 | 22.85% | ✗ | $81K |
| Dec 6, 2022 | Dec 8, 2022 | Giuffre Randall Michael | Director | Buy | 91.3 | +24,874 | 11.06% | ✗ | $34.7K |
| Dec 2, 2022 | Dec 6, 2022 | Von Koch Thomas | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 5, 2022 | Dec 5, 2022 | Pilnik Richard D. | Director | Buy | 91.3 | +35,000 | 29.33% | ✗ | $48.5K |
| Dec 1, 2022 | Dec 5, 2022 | Giuffre Randall Michael | Director | Buy | 60.0 | +819 | 0.37% | ✗ | $974.6 |
| Nov 29, 2022 | Dec 1, 2022 | Giuffre Randall Michael | Director | Buy | 95.0 | +67,228 | 31.85% | ✗ | $80.5K |
| Nov 16, 2022 | Nov 16, 2022 | Pauls Dietrich John | CEO | Buy | 91.3 | +20,000 | 55.86% | ✗ | $24.2K |
| Sep 13, 2022 | Sep 15, 2022 | Daves Julie VanOrsdel | SVP Clinical Development Oper. | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 15, 2022 | Daves Julie VanOrsdel | SVP Clinical Development Oper. | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 8, 2022 | Jul 21, 2022 | Von Koch Thomas | 10% Owner | Buy | 92.5 | +207,974 | 7.85% | ✗ | $275.9K |
| Jul 21, 2022 | Von Koch Thomas | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 1, 2022 | Jun 2, 2022 | Pauls Dietrich John | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2022 | Jun 2, 2022 | Kellen Scott | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2022 | Jun 2, 2022 | Burroughs Amy L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2022 | Jun 2, 2022 | Giuffre Randall Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2022 | Jun 2, 2022 | Parsons James T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2022 | Jun 2, 2022 | Pilnik Richard D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2022 | Jun 2, 2022 | Semba Charles Pauling | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2022 | Feb 2, 2022 | Cundari Dominic R | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 2, 2022 | Cundari Dominic R | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 3, 2022 | Jan 5, 2022 | Gruis Kirsten L | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 5, 2022 | Gruis Kirsten L | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 3, 2022 | Jan 3, 2022 | Burroughs Amy L. | Director | Neutral | 90.0 | +11,182 | 24.88% | ✗ | - |